JMSCR Vol 06 Issue 10 Page October 2018

Similar documents
Address for Correspondence : Dr. J. R. Rawal, Professor & Head, U N Mehta Institute of Cardiology & Research Centre, Civil Hospital, Ahmedabad.

Clinical Phenotypes and In-hospital Management and Prognosis in Diabetic versus Non-diabetic Patients with Acute Heart Failure in ALARM-HF Registry

The Association of Hyponatremia with Race, Ethnicity, and Gender in Patients Admitted for Acute Decompensated Heart Failure Diagnoses

Keynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes?

FREQUENCY OF HYPONATREMIA AND IN-HOSPITAL CLINICAL OUTCOMES IN THESE PATIENTS HOSPITALIZED FOR HEART FAILURE ABSTRACT

Clinical Risk Prediction Tools in Patients Hospitalized With Heart Failure

Gender Differences in Comorbidities of Heart Failure Patients with Preserved or Reduced Left Ventricular Ejection Fraction

Management of Acute Heart Failure

Biomedical Research 2016; 27 (3): ISSN X

Rate of Heart failure guideline adherence in a tertiary care center in India after accounting for the therapeutic contraindications.

Hyponatremia as a Cardiovascular Biomarker

Clinical Pathways Heart Failure Webinar AMGA May

Clinical Profile Of Patients With Hyponatremia Admitted In Medical ICU.

Οξεία καρδιακή ανεπάρκεια: Ποιες παράμετροι συμβάλλουν στη διαστρωμάτωση κινδύνου των ασθενών;

Pearls in Acute Heart Failure Management

JMSCR Vol 05 Issue 11 Page November 2017

Correction of hypervolaemic hypernatraemia by inducing negative Na + and K + balance in excess of negative water balance: a new quantitative approach

Heart failure (HF) is a complex clinical syndrome that results in the. impairment of the heart s ability to fill or to pump out blood.

The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF)

A Study Conducted At A Tertiary Care Teaching Institute in Chennai, on The Clinical And Etiological Profile Of Patients With Acute Heart Failure.

The Failing Heart in Primary Care

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

A Study To Evaluate The Efficacy Of Tolvaptan In Correction Of Hyponatremia And Its Effect On..

Οξεία Καρδιακή Ανεπάρκεια: Κλινική εικόνα, ταξινόμηση κινδύνου & προγνωστικοί δείκτες

Improving Quality of Care and Outcomes for Heart Failure

ORIGINAL ARTICLE HYPONATREMIA IN ELDERLY *Dr. T. Prabhu. Annamalai University, Annamalainagar , Tamilnadu, India

Hyponatremia and In-Hospital Mortality in Patients Admitted for Heart Failure (from the ATTEND Registry)

The Role of Information Technology in Disease Management: A Case for Heart Failure

Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience

Hyponatremia in Heart Failure: why it is important and what should we do about it?

JMSCR Vol 05 Issue 01 Page January 2017

Inotropes are linked to Increased Mortality in Heart Failure

Impact of Change in Serum Sodium Concentration on Mortality in Patients Hospitalized With Heart Failure and Hyponatremia

ORIGINAL ARTICLE. Keywords: Hyponatremia; Predictor of clinical outcomes; Hospitalized heart failure; East Asians

Uri Elkayam, MD. Professor of Medicine University of Southern California Keck School of Medicine

Stopping the Revolving Door of ADHF

Contrast Induced Nephropathy

JMSCR Vol 05 Issue 01 Page January 2017

State of the Art Treatment - Hyponatremia, Heart Rate, et al

Journal of the American College of Cardiology Vol. 43, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Tips & tricks on how to treat an acute heart failure patient with low cardiac output and diuretic resistance

Clinical Investigations

Heart Failure Guidelines For your Daily Practice

NATIONAL HEART FAILURE REGISTRY - ICC

Impact of Change in Serum Sodium Concentration on Mortality. in Patients Hospitalized with Heart Failure and Hyponatremia

The Cardiorenal Syndrome in Heart Failure

Topic Page: congestive heart failure

What s new in the 2017 heart failure guidelines. Prof.Dr.Mehmet Birhan YILMAZ, FESC, FACC, FHFA

Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure

Heart Failure Background, recognition, diagnosis and management

Heart Failure A Team Approach Background, recognition, diagnosis and management

Dr Micheal Looney Consultant Anaesthetist Connolly Hospital Blanchardstown. To Delay or Not to Delay Hip Fracture Surgery

Copeptin in heart failure: Associations with clinical characteristics and prognosis

Cardiology: Open Access

Study of incidence of medical neurological causes of hyponatremia

Cardio-Renal Syndrome in Acute Heart Failure:

Hyponatremia and Worsening Sodium Levels Are Associated With Long-Term Outcome in Patients Hospitalized for Acute Heart Failure

Reassessing treatment of acute heart failure syndromes: the ADHERE Registry

International Journal of Biological & Medical Research

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE

Therapeutic Targets and Interventions

JMSCR Vol 04 Issue 12 Page December 2016

Cardiorenal Syndrome: Clinical Outcome Study

Ultrafiltration in Decompensated Heart Failure. Description

Innovation therapy in Heart Failure

A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c

JMSCR Vol 05 Issue 10 Page October 2017

Outcomes of correcting hyponatremia in patients with myocardial infarction

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

HEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida

Trials Enrolled subjects Findings Fox et al. 2014, SIGNIFY 1

Checklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute

Cardiorenal Syndrome: What the Clinician Needs to Know. William T. Abraham, MD Director, Division of Cardiovascular Medicine

Pivotal Role of Renal Function in Acute Heart failure

State of the Art: acute heart failure Is it just congestion?

JMSCR Vol 05 Issue 06 Page June 2017

Case (Coding Nightmare) Current Dilemmas in Heart Failure : Closing the Gap between Clinical Care and Coding. Current Dilemmas in Heart Failure :

The Impact of Smoking on Acute Ischemic Stroke

Gerasimos Filippatos MD, FESC, FCCP, FACC

ORIGINAL ARTICLE. Editorial p Methods. Heart Failure

Strategies to Reduce Heart Failure Hospitalizations and Readmissions: How Low Can We Go?

The role of remote monitoring in preventing readmissions after acute heart failure

Study of association of mortality with electrolyte abnormalities in children admitted in pediatric intensive care unit

Talking points included in this deck are for internal/speaker use only, and are not to be distributed.

Implementing the CardioMEMS HF System into the Management of Heart Failure Patients

The Triple Threat. Cardiac Care in the NT Annual Workshop 2017 is proudly supported by:

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure

Heart Failure Etiology and Response to Milrinone in Decompensated Heart Failure Results From the OPTIME-CHF Study

9/14/2017 HEART FAILURE IN OBS NO RELEVANT DISCLOSURES IRRELEVANT DISCLOSURES OBJECTIVES WHY HEART FAILURE

Heart Failure: Guideline-Directed Management and Therapy

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Antialdosterone treatment in heart failure

Metoprolol CR/XL in Female Patients With Heart Failure

The NEW Heart Failure Guidelines

ORIGINAL INVESTIGATION. The Benefit of Implementing a Heart Failure Disease Management Program

Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?

Acute Heart Failure: Diagnosis and Risk Assessment in the Emergency Department

HYPONATREMIA AND ITS MANAGEMENT IN PATIENTS WITH HEART FAILURE

Transcription:

www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i10.94 Hyponatremia in Congestive Cardiac Failure Authors Saravana Madhav S 1*, Nanjil Kumaran A 2, Vijayakumar N 3, Umarani R 4 *1 Post graduate, 2,3 Lecturer of Medicine, 4 Professor of Medicine Department of Medicine, RMMCH, Chidambaram-608002, Tamilnadu, India Email: saranmadhav@gmail.com Abstract Hyponatremia is the most common electrolyte abnormality in hospitalized patients with congestive cardiac failure. The prevalence in hospitalized patients is 20 25%. This study was done in RMMCH among congestive cardiac failure cases admitted between September 2016 and June 2018. The outcomes of the study was done based on functional status of left ventricle and other risk factors of cardiac failure were studied. Keywords:, congestive cardiac failure, ejection fraction. Introduction The normal range of serum sodium is 135-145 meq/l. Its homeostasis is vital to the functioning of the cell. An imbalance in the regulation of total body water can lead to abnormal sodium levels. Congestive cardiac failure is associated with disturbance in water homeostasis leading to dysnatremias. Hyponatremia is defined as concentration of sodium less than 135 meq/l (1). It occurs when there is excess of water in relation to sodium. It is the most common electrolyte disorder in hospitalized patients and more so in CCF patients. A disturbance in total body water regulation leading to decreased clearance of solute free water and the consequent inability to match the urine output to the amount of water ingested leads to dilutional. The pathogenesis of is multifactorial and linked to the prognosis. (2) Hypernatremia is defined as concentration of sodium more than 145 meq/l. (1) Hypernatremia is uncommon compared to in CCF patients. However if present, it is associated with increased mortality. Recent studies have demonstrated significant relation to mortality and morbidity for patients admitted with CCF and dysnatremia (3,4). Several studies have indicated the relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure (5,6,7) So we undertook a study in our tertiary care hospital, among CCF cases, in order to establish a relation between dysnatremia and congestive cardiac failure among cases admitted in our hospital. Aim The aim of the study is to find the prevalence, clinical profile of dysnatremia, impact of dysnatremia in morbidity and in hospital mortality in congestive cardiac failure. Left ventricular function and ejection fraction correlation with dysnatremia will also be done. Saravana Madhav S et al JMSCR Volume 06 Issue 10 October 2018 Page 570

Objectives 1. To find out the prevalence and clinical profile of dysnatremia in patients with congestive cardiac failure. 2. To estimate the impact of dysnatremia on morbidity and in hospital mortality of congestive cardiac failure. 3. Correlation of ejection fraction and left ventricular function with sodium levels in congestive cardiac failure. Materials and Methods This is an observational study, conducted during September 2016 to June 2018. During this period all the patients presenting with congestive cardiac failure, admitted to intensive care units and medical wards in RMMCH were studied. Inclusion Criteria All patients more than 18 years presenting with CCF with serum sodium level <135 mmol/l (), borderline - 135 to 137 mmol/l, borderline hypernatremia - 143 to 145 mmol/l, serum sodium level > 145mmol/L (hypernatremia). Exclusion Criteria 1. Post operative patients 2. Head injury 3. Fever 4. Patients on Mechanical ventilation 5. Gastric motility disorders, 6. Patients on AVP antagonist. Study Total cases that were enrolled in the study was 50. In the study 23 male patients and 27 female patients were enrolled. Out of the fifty cases 24 cases had, 2 cases had hypernatremia and remaining 24 cases had. A. Demographic Profile 1. Distribution of Cases Total cases included in study = 50 cases =24(48%) hypernatremia cases= 2 (4%) cases =24(48%) cases <135 borderline 135-137 borderline hypernatremia 143-145 hypernatremia >145 Fig 1: Distribution of cases among hypo and hypernatremia Saravana Madhav S et al JMSCR Volume 06 Issue 10 October 2018 Page 571

2. Age Distribution cases 40-50 years 51-60 years 61-70 years > 71 years Fig 2 Age distribution of cases of High incidence of was found between the age group between 61 and 70 years. 3. Sex Distribution 13 12.5 12 11.5 11 10.5 10 MALE FEMALE Fig 3 Male to female ratio of Among 24 cases of, 13 were males and the remaining 11 were females. B. Risk Factors Comparison between Cases S. No Risk factors Hyponatremia Normonatremia 1 CAD 11 (45%) 13 (54%) 2 Hypertension 12 (50%) 8 (33%) 3 Type 2 diabetes mellitus 12 (50%) 3 (12%) 4 RHD 2 (8%) 1 (4%) 5 Hypothyroidism 1 (4%) nil 6 Anemia 17 (70%) 12 (50%) 7 Others 5 (20%) 5 (20%) Coronary artery disease, hypertension, diabetes and anemia were found to be risk factors for. Among these modifiable factors were hypertension, diabetes and anemia. Saravana Madhav S et al JMSCR Volume 06 Issue 10 October 2018 Page 572

C. Comparison of Ejection Fraction between Hyponatremia and Normonatremia 10 8 6 4 2 0 20-30 31-40 41-50 51-60 >60 Fig 4: comparison of ejection fraction More cases with reduced ejection fraction were found in group. D. Hospital Stay Average hospital stay 5.6 5.4 5.2 5 4.8 4.6 4.4 hypernatremia Average hospital stay Fig 5: Average hospital stay The morbidity in terms of average hospital stay was 5.5 days for CCF cases with and hypernatremia, whereas it was 4.7 days for normomatremic cases. Conclusion Out of 50 patients, was found in 24 cases (48%) and hypernatremia in 2 cases (4%). Many modifiable risk factors like anemia, diabetes and hypertension constituted many of the cases of. Among modifiable risk factors, anemia was found to be significant with p <0.01. More cases were found among older individuals and particularly male cases. In our study we found that the incidence of was high among congestive Saravana Madhav S et al JMSCR Volume 06 Issue 10 October 2018 Page 573

cardiac failure cases. The incidence being high among elderly male patients and was associated with prolonged hospital stay. Among the modifiable risk factors, anemia was found to have a statistically significant association. References 1. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581 1589. 2. Sica DA. Hyponatremia and heart failurepathophysiology and implications. Congest Heart Fail 2005;11:274 277. 3. Filippatus TD, Elisaf MS. Hyponatraemia in patients with heart failure. World J Cardiol 2013;5:317-28. 4. Klein L, O Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, et al. Lower serum sodium is associated with increased shortterm mortality in hospitalized patients with worsening heart failure: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005;111:2454-60. 5. Gheorghiade M, Abraham WT, Albert NM, Stough WG, Greenberg BH, O Connor CM, et al. Relationship between admission serum sodium concentrations and clinical outcomes in patients hospitalized for heart failure: An analysis from the OPTIMISE-HF registry. Eur Heart J 2007;28:980-8. 6. Ghosh S, Smith J, Dexter J, Carroll- Hawkins C, O Kelly N. Mild hyponatraemia and short outcomes in patients with heart failure in the community. Br J Cardiol 2011; 18:133-7. 7. Bettari L, Fiuzat M, Shaw LK, Wojdyla DM, Metra M, Felker GM, et al. Hyponatremia and long-term outcomes in chronic heart failure An observational study from the duke databank for cardiovascular diseases. J Card Fail 2012;18:74-81. 8. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientifi c Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: Findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-8. Saravana Madhav S et al JMSCR Volume 06 Issue 10 October 2018 Page 574